
|Articles|April 1, 2003
Type A Versus Type B
Author(s)Terry Troy
Rancho Mirage, Calif. -- A recent study rating the effects of botulinum toxin B in the treatment of hyperkinetic facial wrinkles showed that Myobloc is an effective treatment for interglabellar wrinkles. And while Myobloc showed some advantages over the more commonly used Botox (botulinum toxin A), the longevity of the treatment is about one or two weeks less, even at higher dosages.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
3
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
4
Dermatology Conferences and Meetings Calendar: December 2025
5


















